Novavax Stock May Soar 379%, According to Wall Street. Is the Stock a Buy Right Now?

Novavax (NVAX 3.21%) soared more than 2,700% early in the pandemic as investors bet on its ability to bring a coronavirus vaccine to market. The company followed through on that -- but not as quickly as planned. Novavax's product launched more than a year after those of rivals. This meant Novavax missed out on the biggest revenue opportunity, disappointing investors. As a result, the stock plummeted, and today is down 98% from its peak.The vaccine maker has gone through difficult times, having to lower cost ...